For example, cytoplasmic anchorage of CRBN, and the resulting sequestration from Ikaros and Aiolos may attenuate their degradation in response to lenalidomide or pomalidomide, thereby providing a mechanism by which multiple myeloma cells can acquire resistance to these drugs. This evidence concerns the gene CRBN and AL amyloidosis.